Eribulin disrupts EB1-microtubule plus-tip complex formation

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Eribulin mesylate is a synthetic analog of halichondrin B known to bind tubulin and microtubules, specifically at their protein rich plus-ends, thereby dampening microtubule (MT) dynamics, arresting cells in mitosis, and inducing apoptosis. The proteins which bind to the MT plus-end are known as microtubule plus-end tracking proteins (CTIPs) and have been shown to promote MT growth and stabilization. Eribulin's plus-end binding suggests it may compete for binding sites with known CTIP proteins such as End-binding 1 (EB1). To better understand the impact of eribulin plusend binding in regard to the proteins which normally bind there, cells expressing GFP-EB1 were treated with various concentrations of eribulin. In a concentration dependent manner, GFP-EB1 became dissociated from the MT plus-ends following drug addition. Similar results were found with immuno-stained fixed cells. Cells treated with low concentrations of eribulin also showed decreased ability to migrate, suggesting the decrease in MT dynamics may have a downstream effect. Extended exposure of eribulin to cells leads to total depolymerization of the MT array. Taken together, these data show eribulin effectively disrupts EB1 CTIP complex formation, providing mechanistic insights into the impact of eribulin on MT dynamics.

Original languageEnglish (US)
Pages (from-to)3218-3221
Number of pages4
JournalCell Cycle
Volume13
Issue number20
DOIs
StatePublished - Oct 15 2014

Fingerprint

eribulin
Microtubules
Proteins

Keywords

  • EB1
  • Eribulin
  • Microtubules
  • Migration
  • Taxol

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Eribulin disrupts EB1-microtubule plus-tip complex formation. / O'Rourke, Brian; Yang, Chia-Ping H.; Sharp, David J.; Band Horwitz, Susan.

In: Cell Cycle, Vol. 13, No. 20, 15.10.2014, p. 3218-3221.

Research output: Contribution to journalArticle

@article{583689035f0a443294cd02c27e9b04a6,
title = "Eribulin disrupts EB1-microtubule plus-tip complex formation",
abstract = "Eribulin mesylate is a synthetic analog of halichondrin B known to bind tubulin and microtubules, specifically at their protein rich plus-ends, thereby dampening microtubule (MT) dynamics, arresting cells in mitosis, and inducing apoptosis. The proteins which bind to the MT plus-end are known as microtubule plus-end tracking proteins (CTIPs) and have been shown to promote MT growth and stabilization. Eribulin's plus-end binding suggests it may compete for binding sites with known CTIP proteins such as End-binding 1 (EB1). To better understand the impact of eribulin plusend binding in regard to the proteins which normally bind there, cells expressing GFP-EB1 were treated with various concentrations of eribulin. In a concentration dependent manner, GFP-EB1 became dissociated from the MT plus-ends following drug addition. Similar results were found with immuno-stained fixed cells. Cells treated with low concentrations of eribulin also showed decreased ability to migrate, suggesting the decrease in MT dynamics may have a downstream effect. Extended exposure of eribulin to cells leads to total depolymerization of the MT array. Taken together, these data show eribulin effectively disrupts EB1 CTIP complex formation, providing mechanistic insights into the impact of eribulin on MT dynamics.",
keywords = "EB1, Eribulin, Microtubules, Migration, Taxol",
author = "Brian O'Rourke and Yang, {Chia-Ping H.} and Sharp, {David J.} and {Band Horwitz}, Susan",
year = "2014",
month = "10",
day = "15",
doi = "10.4161/15384101.2014.950143",
language = "English (US)",
volume = "13",
pages = "3218--3221",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "20",

}

TY - JOUR

T1 - Eribulin disrupts EB1-microtubule plus-tip complex formation

AU - O'Rourke, Brian

AU - Yang, Chia-Ping H.

AU - Sharp, David J.

AU - Band Horwitz, Susan

PY - 2014/10/15

Y1 - 2014/10/15

N2 - Eribulin mesylate is a synthetic analog of halichondrin B known to bind tubulin and microtubules, specifically at their protein rich plus-ends, thereby dampening microtubule (MT) dynamics, arresting cells in mitosis, and inducing apoptosis. The proteins which bind to the MT plus-end are known as microtubule plus-end tracking proteins (CTIPs) and have been shown to promote MT growth and stabilization. Eribulin's plus-end binding suggests it may compete for binding sites with known CTIP proteins such as End-binding 1 (EB1). To better understand the impact of eribulin plusend binding in regard to the proteins which normally bind there, cells expressing GFP-EB1 were treated with various concentrations of eribulin. In a concentration dependent manner, GFP-EB1 became dissociated from the MT plus-ends following drug addition. Similar results were found with immuno-stained fixed cells. Cells treated with low concentrations of eribulin also showed decreased ability to migrate, suggesting the decrease in MT dynamics may have a downstream effect. Extended exposure of eribulin to cells leads to total depolymerization of the MT array. Taken together, these data show eribulin effectively disrupts EB1 CTIP complex formation, providing mechanistic insights into the impact of eribulin on MT dynamics.

AB - Eribulin mesylate is a synthetic analog of halichondrin B known to bind tubulin and microtubules, specifically at their protein rich plus-ends, thereby dampening microtubule (MT) dynamics, arresting cells in mitosis, and inducing apoptosis. The proteins which bind to the MT plus-end are known as microtubule plus-end tracking proteins (CTIPs) and have been shown to promote MT growth and stabilization. Eribulin's plus-end binding suggests it may compete for binding sites with known CTIP proteins such as End-binding 1 (EB1). To better understand the impact of eribulin plusend binding in regard to the proteins which normally bind there, cells expressing GFP-EB1 were treated with various concentrations of eribulin. In a concentration dependent manner, GFP-EB1 became dissociated from the MT plus-ends following drug addition. Similar results were found with immuno-stained fixed cells. Cells treated with low concentrations of eribulin also showed decreased ability to migrate, suggesting the decrease in MT dynamics may have a downstream effect. Extended exposure of eribulin to cells leads to total depolymerization of the MT array. Taken together, these data show eribulin effectively disrupts EB1 CTIP complex formation, providing mechanistic insights into the impact of eribulin on MT dynamics.

KW - EB1

KW - Eribulin

KW - Microtubules

KW - Migration

KW - Taxol

UR - http://www.scopus.com/inward/record.url?scp=84912094905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912094905&partnerID=8YFLogxK

U2 - 10.4161/15384101.2014.950143

DO - 10.4161/15384101.2014.950143

M3 - Article

VL - 13

SP - 3218

EP - 3221

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 20

ER -